Substance / Medication

Bebtelovimab

Overview

Active Ingredient
bebtelovimab
RxNorm CUI
2592360

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
SARS-CoV-2 neutralizing antibody bebtelovimab - a systematic scoping review and meta-analysis.
Liew Mabel Nyit Yi, Kua Kok Pim, Lee Shaun Wen Huey et al. · Front Immunol · 2023
PMID: 37701439Meta-AnalysisFull text (PMC)
The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis.
Luo Jie, Li Toni, Liu Changying et al. · J Infect · 2023
PMID: 37085048Meta-AnalysisFull text (PMC)
Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest.
Gearges Christina, Haider Hibah, Rana Vishal et al. · Crit Care Explor · 2022
PMID: 36003828Case ReportFull text (PMC)
Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19.
Rowan Christopher G, Nichols Russell M, Dhopeshwarkar Neil et al. · Pulm Ther · 2025
PMID: 39722116OtherFull text (PMC)
SARS-CoV-2 variants and bebtelovimab: immune escape mechanisms revealed by computational studies.
Roy Rakesh Kumar, Sharma Madhur, Patra Niladri · Phys Chem Chem Phys · 2024
PMID: 39618233Other
Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19.
Kapur Rohan, Okumura Kenji, Feola Nicholas et al. · Cureus · 2023
PMID: 37313067OtherFull text (PMC)
Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants.
Wang Xuejun, Yang Yang, Song Zhifei et al. · J Med Virol · 2023
PMID: 36756927Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bebtelovimab (substance)
SNOMED CT
1208391007
UMLS CUI
C5565647
RxNorm CUI
2592360

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.